Jpmorgan Chase & CO Exact Sciences Corp Transaction History

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Exact Sciences Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 503,969 shares of EXAS stock, worth $29.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

503,969

Previous 3,493,491 85.57%

Holding current value

$29.9 Million

Previous $196 Million 88.89%

% of portfolio

0.0%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$43.04 - $58.51 $129 Million - $175 Million	-2,989,522 Reduced 85.57%	503,969 $21.8 Million
Q4 2024 Feb 12, 2025	SELL	$49.33 - $71.97 $87 Million - $127 Million	-1,762,792 Reduced 33.54%	3,493,491 $196 Million
Q3 2024 Dec 26, 2024	BUY	$42.43 - $70.83 $38.8 Million - $64.8 Million	914,682 Added 21.07%	5,256,283 $358 Million
Q3 2024 Nov 08, 2024	BUY	$42.43 - $70.83 $38.8 Million - $64.8 Million	914,682 Added 21.07%	5,256,283 $358 Million
Q2 2024 Dec 26, 2024	SELL	$41.33 - $74.26 $37.8 Million - $67.9 Million	-914,682 Reduced 17.4%	4,341,601 $183 Million
Q2 2024 Aug 12, 2024	SELL	$41.33 - $74.26 $332 Million - $597 Million	-8,042,915 Reduced 64.94%	4,341,601 $183 Million
Q1 2024 Dec 26, 2024	BUY	$56.27 - $73.77 $401 Million - $526 Million	7,128,233 Added 135.61%	12,384,516 $855 Million
Q1 2024 May 10, 2024	SELL	$56.27 - $73.77 $242 Million - $318 Million	-4,306,292 Reduced 25.8%	12,384,516 $855 Million
Q4 2023 Dec 26, 2024	BUY	$59.06 - $75.72 $675 Million - $866 Million	11,434,525 Added 217.54%	16,690,808 $1.23 Billion
Q4 2023 Feb 12, 2024	SELL	$59.06 - $75.72 $94.6 Million - $121 Million	-1,601,811 Reduced 8.76%	16,690,808 $1.23 Billion
Q3 2023 Nov 14, 2023	BUY	$65.94 - $99.04 $217 Million - $326 Million	3,293,699 Added 21.96%	18,292,619 $1.25 Billion
Q2 2023 Aug 11, 2023	BUY	$62.68 - $95.05 $65.7 Million - $99.6 Million	1,048,128 Added 7.51%	14,998,920 $1.41 Billion
Q1 2023 May 18, 2023	BUY	$47.19 - $70.77 $346,280 - $519,310	7,338 Added 0.05%	13,950,792 $946 Million
Q1 2023 May 11, 2023	BUY	$47.19 - $70.77 $292 Million - $438 Million	6,193,738 Added 79.92%	13,943,454 $946 Million
Q4 2022 Feb 13, 2023	BUY	$30.35 - $53.15 $94.5 Million - $166 Million	3,115,288 Added 67.22%	7,749,716 $384 Million
Q3 2022 Nov 14, 2022	SELL	$31.97 - $49.37 $15.6 Million - $24.1 Million	-488,962 Reduced 9.54%	4,634,428 $151 Million
Q2 2022 Aug 11, 2022	SELL	$35.61 - $76.23 $4.74 Million - $10.1 Million	-133,113 Reduced 2.53%	5,123,390 $202 Million
Q1 2022 May 11, 2022	BUY	$57.56 - $82.54 $30.9 Million - $44.3 Million	537,107 Added 11.38%	5,256,503 $368 Million
Q4 2021 Feb 10, 2022	BUY	$72.5 - $100.68 $25.6 Million - $35.6 Million	353,329 Added 8.09%	4,719,396 $367 Million
Q3 2021 Nov 12, 2021	BUY	$90.24 - $124.05 $394 Million - $542 Million	4,366,067 New	4,366,067 $417 Million

Others Institutions Holding EXAS

# of Institutions

651

Shares Held

157M

Call Options Held

1.43M

Put Options Held

2.3M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.5B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Exact Sciences Corp Transaction History